Clinical Trial Update: Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed etanercept for preventing complications following hematopoietic stem cell transplantation, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Graft-Versus-Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-06-04